Effect of sex difference on platelet adhesion, spreading and aggregate formation under flow

Summary

There are clear but poorly understood differences in the etiology and prognosis of thrombotic diseases in men and women. Due to the fact that platelets play a central role in the formation of occlusive thrombi in atherosclerotic coronary arteries, previous studies have examined whether sex differences exist for platelets, and have obtained conflicting results. Additionally, due to the increased use of genetically modified mouse models to explore the molecular mechanisms underlying platelet activation and thrombotic disorders, it is critical to determine if sex is a confounding variable. Our study of the role of sex differences in platelet function was designed to utilise purified platelets from inbred paired female/male littermates in order to minimise genetic and environmental variability. In the current study, we demonstrate that platelet adhesion to and spreading on immobilised fibrinogen, thrombin or collagen was equivalent for both female and male mouse platelets. The ability of the soluble agonist thrombin or convulxin to potentiate platelet Pselectin exposure, fibrinogen binding, or adhesion and spreading on immobilised fibrinogen was equivalent for both female and male mouse platelets. Our data show that an equivalent degree of platelet adhesion and aggregation on collagen or fibrinogen under shear flow was observed for both female and male mouse platelets. In conclusion, our data would argue against an intrinsic difference for female mouse platelets in regulating the major functional platelet responses: platelet adhesion, spreading, or aggregation under flow.

Keywords

Platelet activation - platelet spreading - flow adhesion - sex differences

¹ Current address: Inter-Departmental Program for Polymer Engineering, Technion, Haifa 32000, Israel

• References

• 1 Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383-390.
• 2 Loop FD, Golding LR, MacMillan JP. et al. Coronary artery surgery in women compared with men: analyses of risks and long-term results. J Am Coll Cardiol 1983; 01: 383-390.
• 3 Vaccarino V, Parsons L, Every NR. et al. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341: 217-225.
• 4 Weaver WD, White HD, Wilcox RG. et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. J Am Med Assoc 1996; 275: 777-782.
• 5 Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med 1993; 329: 247-256.
• 6 Johnson M, Ramey E, Ramwell PW. Sex and age differences in human platelet aggregation. Nature 1975; 253: 355-357.
• 7 Faraday N, Goldschmidt-Clermont PJ, Bray PF. Gender differences in platelet GPIIb-IIIa activation. Thromb Haemost 1997; 77: 748-754.
• 8 Becker DM, Segal J, Vaidya D. et al. Sex differences in platelet reactivity and response to low-dose aspirin therapy. J Am Med Assoc 2006; 295: 1420-1427.
• 9 Beyan C, Kaptan K, Ifran A. et al. Effect of sex difference on platelet aggregation using an optical method in healthy subjects. Clin Lab Haematol 2006; 28: 14-16.
• 10 Neuger J, El AKhoury, Kjellman BF. et al. Platelet serotonin functions in untreated major depression. Psychiatry Res 1999; 85: 189-198.
• 11 Nies AS, Andros EA, Gerber JG. Platelet alpha 2-adrenergic receptor responsiveness is increased in elderly men but not in elderly women. Clin Pharmacol Ther 1992; 52: 605-608.
• 12 Loncar R, Zotz RB, Sucker C. et al. Platelet adhesion onto immobilized fibrinogen under arterial and venous in-vitro flow conditions does not significantly differ between men and women. Thromb J 2007; 05: 5.
• 13 Emms H, Lewis GP. Sex and hormonal influences on platelet sensitivity and coagulation in the rat. Br J Pharmacol 1985; 86: 557-563.
• 14 Torres APDuarte, Ramwell P, Myers A. Sex differences in mouse platelet aggregation. Thromb Res 1986; 43: 33-39.
• 15 Orchard MA, Botting JH. The influence of sex hormones on rat platelet sensitivity to adenosine-diphosphate. Thromb Haemost 1981; 46: 496-499.
• 16 Leng XH, Hong SY, Larrucea S. et al. Platelets of female mice are intrinsically more sensitive to agonists than are platelets of males. Arterioscler Thromb Vasc Biol 2004; 24: 376-381.
• 17 White TC, Berny MA, Robinson DK. et al. The leech product saratin is a potent inhibitor of platelet integrin alpha2beta1 and von Willebrand factor binding to collagen. FEBS J 2007; 274: 1481-1491.
• 18 Thornber K, McCarty O, Watson SP. et al. Distinct but critical roles for integrin [[alpha]]IIb[[beta]]3 in platelet lamellipodia formation on fibrinogen, collagen-related peptide and thrombin. FEBS J 2006; 273: 5032-5043.
• 19 Dhanjal TS, Ross EA, Auger JM. et al. Minimal regulation of platelet activity by PECAM-1. Platelets 2007; 18: 56-67.
• 20 Pearce AC, McCarty OJ, Calaminus SD. et al. Vav family proteins are required for optimal regulation of PLCgamma2 by integrin alphaIIbbeta3. Biochem J 2007; 401: 753-761.
• 21 McCarty OJ, Calaminus SD, Berndt MC. et al. von Willebrand factor mediates platelet spreading through glycoprotein Ib and alpha(IIb)beta3 in the presence of botrocetin and ristocetin, respectively. J Thromb Haemost 2006; 04: 1367-1378.
• 22 Calaminus SD, McCarty OJ, Auger JM. et al. A major role for Scar/WAVE-1 downstream of GPVI in platelets. J Thromb Haemost 2007; 05: 535-541.
• 23 Suzuki-Inoue K, Fuller GL, Garcia A. et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006; 107: 542-549.
• 24 Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88: 186-193.
• 25 Heemskerk JW, Siljander PR, Bevers EM. et al. Receptors and signalling mechanisms in the procoagulant response of platelets. Platelets 2000; 11: 301-306.
• 26 Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. J Am Med Assoc 1991; 265: 1861-1867.
• 27 Anwaar I, Rendell M, Gottsater A. et al. Hormone replacement therapy in healthy postmenopausal women. Effects on intraplatelet cyclic guanosine monophosphate, plasma endothelin-1 and neopterin. J Intern Med 2000; 247: 463-470.
• 28 Bar J, Lahav J, Hod M. et al. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women. Thromb Haemost 2000; 84: 695-700.
• 29 Boudoulas KD, Cooke GE, Roos CM. et al. The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation. Arch Pathol Lab Med 2001; 125: 112-115.
• 30 Elkeles RS, Hampton JR, Mitchell JR. Effect of oestrogens on human platelet behaviour. Lancet 1968; 02: 315-318.
• 31 Miller ME, Thorpe SL, Dores GM. Influence of hormones on platelet intracellular calcium. Thromb Res 1995; 77: 515-530.
• 32 Moro L, Reineri S, Piranda D. et al. Nongenomic effects of 17beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase. Blood 2005; 105: 115-121.
• 33 Ross R, Glomset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 1976; 295: 369-377.